Preventing adverse events of chemotherapy for gastrointestinal cancer by educating patients about the nocebo effect: a randomized-controlled trial.

Michnevich, T; Pan, Y; Hendi, A; Oechsle, K; Stein, A; Nestoriuc, Y

Michnevich, T; Pan, Y; Hendi, A; Oechsle, K; Stein, A; Nestoriuc, Y.

Afiliação

Michnevich T; Department of Psychosomatic Medicine and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. twyla.michnevich@charite.de.
Pan Y; Department of Psychiatry and Psychotherapy, Charité - University Medicine Berlin, Berlin, Germany. twyla.michnevich@charite.de.
Hendi A; Present address: Charité - University Medicine Berlin, Berlin, Germany. twyla.michnevich@charite.de.
Oechsle K; Department of Psychosomatic Medicine and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Stein A; Department of Psychosomatic Medicine and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Nestoriuc Y; Department of Oncology, Asklepios Clinic Barmbek, Hamburg, Germany.

BMC Cancer ; 22(1): 1008, 2022 Sep 23.

Article em En | MEDLINE | ID: mdl-36138381

Assuntos

Neoplasias Gastrointestinais; Efeito Nocebo; Feminino; Neoplasias Gastrointestinais/tratamento farmacológico; Humanos; Masculino; Pessoa de Meia-Idade

Palavras-chave

Adverse events; Chemotherapy; Expectations; Nocebo; Placebo

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Efeito Nocebo / Neoplasias Gastrointestinais Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google